Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnostics

The results of diagnostics of 65 patients with serous ovarian carcinoma are given in the article. Analysis of the investigation has allowed to include 13 patients (20 %) in the group 1 (low grade) and 52 (80 %) in the group 2 (high grade). According to the results of the executed work it is determin...

Full description

Bibliographic Details
Main Authors: O. G. Grigoruk, E. E. Pupkova, L. M. Bazulina, A. F. Lazarev
Format: Article
Language:Russian
Published: ABV-press 2016-09-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/496
_version_ 1797876033536393216
author O. G. Grigoruk
E. E. Pupkova
L. M. Bazulina
A. F. Lazarev
author_facet O. G. Grigoruk
E. E. Pupkova
L. M. Bazulina
A. F. Lazarev
author_sort O. G. Grigoruk
collection DOAJ
description The results of diagnostics of 65 patients with serous ovarian carcinoma are given in the article. Analysis of the investigation has allowed to include 13 patients (20 %) in the group 1 (low grade) and 52 (80 %) in the group 2 (high grade). According to the results of the executed work it is determined that the Immunocytochemical technique allows to verify ovarian carcinoma, differentiating it with carcinoma metastases of the other organs, that is very important for following treatment. In case of sufficient tumour cells in cytological specimens, specimens are valuable material for molecular-genetic researches. According to the results of genetic DNA investigations, suitable for the estimation, there was absence mutation of V600E in the BRAF-gene in all cases. The genetic mutation of KRAS-gene with 5 patients from the group1 (low grade) was noticed. Among them the genetic mutation of G12V was detected in 4 cases and mutation of G12D in 1 case. The mutations in the BRCA1-gene weredetected in 4 cases from the 2th group (high grade) three of them were presented by 5382insC mutation and one of them by T300G mutation. The usage of the multivariate analysis evaluating the cell composition of low and high grade carcinomas was allowed to distinguish the most significant features off ovarian carcinoma cells that will be allow to differentiate them by means of light microscopy.
first_indexed 2024-04-10T01:56:54Z
format Article
id doaj.art-d150c7d38dd642feaacb0b3e5e5c81c1
institution Directory Open Access Journal
issn 1994-4098
1999-8627
language Russian
last_indexed 2024-04-10T01:56:54Z
publishDate 2016-09-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj.art-d150c7d38dd642feaacb0b3e5e5c81c12023-03-13T08:44:36ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272016-09-01122707610.17650/1994-4098-2016-12-2-70-76501Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnosticsO. G. Grigoruk0E. E. Pupkova1L. M. Bazulina2A. F. Lazarev3Алтайский филиал ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России; КГБУЗ «Алтайский краевой онкологический диспансер»;КГБУЗ «Алтайский краевой онкологический диспансер»КГБУЗ «Алтайский краевой онкологический диспансер»Алтайский филиал ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России; КГБУЗ «Алтайский краевой онкологический диспансер»The results of diagnostics of 65 patients with serous ovarian carcinoma are given in the article. Analysis of the investigation has allowed to include 13 patients (20 %) in the group 1 (low grade) and 52 (80 %) in the group 2 (high grade). According to the results of the executed work it is determined that the Immunocytochemical technique allows to verify ovarian carcinoma, differentiating it with carcinoma metastases of the other organs, that is very important for following treatment. In case of sufficient tumour cells in cytological specimens, specimens are valuable material for molecular-genetic researches. According to the results of genetic DNA investigations, suitable for the estimation, there was absence mutation of V600E in the BRAF-gene in all cases. The genetic mutation of KRAS-gene with 5 patients from the group1 (low grade) was noticed. Among them the genetic mutation of G12V was detected in 4 cases and mutation of G12D in 1 case. The mutations in the BRCA1-gene weredetected in 4 cases from the 2th group (high grade) three of them were presented by 5382insC mutation and one of them by T300G mutation. The usage of the multivariate analysis evaluating the cell composition of low and high grade carcinomas was allowed to distinguish the most significant features off ovarian carcinoma cells that will be allow to differentiate them by means of light microscopy.https://ojrs.abvpress.ru/ojrs/article/view/496серозный рак яичникацитологическая и иммуноцитохимическая диагностикамутации генов brca1 / 2krasbraf
spellingShingle O. G. Grigoruk
E. E. Pupkova
L. M. Bazulina
A. F. Lazarev
Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnostics
Опухоли женской репродуктивной системы
серозный рак яичника
цитологическая и иммуноцитохимическая диагностика
мутации генов brca1 / 2
kras
braf
title Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnostics
title_full Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnostics
title_fullStr Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnostics
title_full_unstemmed Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnostics
title_short Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnostics
title_sort serous ovarian carcinoma cytological and immunocytochemical and molecular genetic diagnostics
topic серозный рак яичника
цитологическая и иммуноцитохимическая диагностика
мутации генов brca1 / 2
kras
braf
url https://ojrs.abvpress.ru/ojrs/article/view/496
work_keys_str_mv AT oggrigoruk serousovariancarcinomacytologicalandimmunocytochemicalandmoleculargeneticdiagnostics
AT eepupkova serousovariancarcinomacytologicalandimmunocytochemicalandmoleculargeneticdiagnostics
AT lmbazulina serousovariancarcinomacytologicalandimmunocytochemicalandmoleculargeneticdiagnostics
AT aflazarev serousovariancarcinomacytologicalandimmunocytochemicalandmoleculargeneticdiagnostics